Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Drug Discovery (4)
182 Articles Available
4
8
Can't find what you're looking for? Try our
advanced search
.
Drug Discovery
Heart-on-a-Chip Mimics Drug Response Seen in Humans: In Vitro Approach Provides Predictive Platform for Human-Based Drug Discovery
PR-M08-19-NI-045
Genomic Research
GSK Joins Forces with the University of California to Advance Genomic Research and Improve Drug Discovery
PR-M06-19-NI-018
CRISPR
CRISPR Tech is Going Gold
PAO-M05-19-NI-040
Drug Delivery
Drug Delivery Tech Based on Sea Lamprey Immune System Could Facilitate Treatment of Brain Disorders
PAO-M05-19-NI-030
Novel Therapies
Q: What truly novel therapies in the earliest stages of discovery and development do you believe will have a significant impact in the future?
PAP-Q2-2019-NI-007
Drug Development
HPV Treatment May Also Fight Rare Respiratory Disease
PAO-M04-19-NI-009
Partnership
Takeda and HemoShear Therapeutics Extend Exclusive Drug Discovery Partnership in Liver Diseases
PR-M03-19-NI-059
Artificial Intelligence
Pharma Makes Moves to Leverage Artificial Intelligence
PAP-Q1-2019-NI-006
Drug Discovery
A Research Partner With Proven Results
PAP-Q1-2019-CL-038
HIV
Long-Acting Injectable HIV Treatment Regimen of Rilpivirine and Cabotegravir Demonstrated Comparable Safety and Efficacy to Daily Oral HIV Therapy
PR-M03-19-NI-033
PTSD
The VA Recognizes Ketamine as an Emergency Treatment for PTSD and Depression Patients at High Suicide Risk
PR-M10-18-NI-012
Drug Development
Bayer Gets FDA Approval for Hemophilia A Drug
PAO-M09-18-NI-006
Research
Researchers Make Discovery about Leptin Resistance
PAO-M08-18-NI-025
CRO
From Internal Lab to External Service Provider
PAO-M08-18-NI-009
Clinical Data
Pulmatrix Announces Positive Top-Line Preliminary Results from Part 3 of the 3-Part Phase 1/1b Clinical Trial of Pulmazole
PR-M07-18-NI-058
Drug Development
New Antibiotic to be Tested against Potential Bioweapons
PAO-M07-18-NI-009
Drug Discovery
Peptron Announces Published Data Showing a New Sustained-Release Exendin-4 Formulation Prevents Neurodegeneration in a Parkinson's Disease Model
PR-M07-18-NI-052
Drug Discovery
Could a Bispecific Antibody Be A Functional Cure for AIDS?
PAO-M06-18-NI-015
Drug Approval
WuXi STA First CDMO to Support the Approval of an Innovative Drug in China Through the "MAH" Pilot
PR-M06-18-NI-057
FDA
FDA Advisory Committee Votes in Favor of Cardinal Health's INCRAFT® AAA Stent Graft System for the Endovascular Treatment of Infrarenal Abdominal Aortic Aneurysms
PR-M06-18-NI-055
Drug Discovery
Eisai Inc. to Launch Center for Genetics Guided Dementia Discovery in Cambridge, Massachusetts
PR-M06-18-NI-044
Artificial Intelligence
WuXi AppTec Leads Strategic Investment in Insilico Medicine to Accelerate Drug Discovery Using Next-Generation Artificial Intelligence
PR-M06-18-NI-037
Clinical Data
New Data Demonstrate Artemis Therapeutics' Artemisone May Be An Effective Inhibitor Of Human CMV Replication
PR-M06-18-NI-030
R&D
Researchers Find Link between Tuberculosis and Parkinson’s Disease
PAO-M05-18-NI-025
«
4
8
»
.svg)